Howard Mayer - 22 Jun 2022 Form 4 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Role
Director
Signature
/s/ Jane Henderson attorney-in-fact for Howard Mayer
Issuer symbol
IVVD
Transactions as of
22 Jun 2022
Net transactions value
$0
Form type
4
Filing time
24 Jun 2022, 16:36:24 UTC
Previous filing
19 Jan 2022
Next filing
11 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IVVD Stock Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 22 Jun 2022 Common Stock 75,000 $3.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 22, 2022 and vests in full on the earlier of (i) June 22, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to continued service through the vesting date.